Indian diagnostics chains on the cusp of inflection, says Emkay; initiates coverage on these 2 stocks with 'buy'
Emkay Global initiates coverage on diagnostic stocks such as Dr Lal Path Labs, Metropolis Healthcare, and Vijaya Diagnostics, highlighting potential growth opportunities in Indian healthcare sector post pandemic.
DNA News Desk
0
11
Emkay Global initiates coverage on diagnostic stocks such as Dr Lal Path Labs, Metropolis Healthcare, and Vijaya Diagnostics, highlighting potential growth opportunities in Indian healthcare sector post pandemic.
